About FormMed
FormMed is a company based in Frankfurt Am Main (Germany) founded in 1996 by Martin Lemperle was acquired by Avedon Capital Partners in July 2022. The company has 122 employees as of December 31, 2021. FormMed offers products and services including Micronutrient Preparations and Online Shop Products. FormMed operates in a competitive market with competitors including Fagron, RareStone Group, Revelation Pharma, Pharmedium and Syntis, among others.
- Headquarter Frankfurt Am Main, Germany
- Employees 122 as on 31 Dec, 2021
- Founders Martin Lemperle
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Formmed Healthcare Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
122
as on Dec 31, 2021
-
Acquired by
Avedon Capital Partners
(Jul 29, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FormMed
FormMed offers a comprehensive portfolio of products and services, including Micronutrient Preparations and Online Shop Products.
Supplements for treatments in medical fields like dermatology.
Platform for purchasing over 400 health preparations.
Funding Insights of FormMed
Detailed funding history for FormMed
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in FormMed
FormMed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Avedon Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm supporting growth in niche markets through private equity.
|
Locked | Locked | Locked |
Investor details for FormMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FormMed
Investment portfolio details for FormMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FormMed
Detailed financials for FormMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Formmed Comparisons
Peer comparison for FormMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FormMed
FormMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fagron, RareStone Group, Revelation Pharma, Pharmedium and Syntis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug compounding services are provided by Fagron.
|
|
| Locked | Locked | Locked |
Provider of network and treatments to individuals and their families affected by rare diseases drugs
|
|
| Locked | Locked | Locked |
A network of compounding pharmacies is operated nationwide.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided to healthcare facilities nationwide.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided by Syntis in healthcare.
|
|
| Locked | Locked | Locked |
Compounding pharmacy services are offered independently in Breda.
|
Detailed competitors of FormMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Formmed
Complete news archive for FormMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FormMed
FormMed was founded in 1996.
FormMed is headquartered in Frankfurt Am Main, Germany. It is registered at Frankfurt Am Main, Hesse, Germany.
As of Dec 31, 2021, the latest employee count at FormMed is 122.
FormMed was founded in 1996 by Martin Lemperle in Frankfurt am Main, Germany. Operations focus on the healthcare sector, where services supporting physician-assisted micro-nutrient medicine are delivered. These include consultations and treatments aimed at nutrient deficiencies, with activities centered in Germany. The company maintains a presence through its domain formmed.de, serving medical professionals and patients in the region.
FormMed's top competitors include Syntis, Ignota Labs and Fagron.
FormMed offers Micronutrient Preparations and Online Shop Products.
FormMed has 1 investor. Key investors include Avedon Capital Partners.